APA (7th ed.) Citation

Falloon, J., Ji, F., Curtis, C., Bart, S., Sheldon, E., Krieger, D., . . . Esser, M. T. (2016). A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant. Vaccine, 34(25), 2847. https://doi.org/10.1016/j.vaccine.2016.04.002

Chicago Style (17th ed.) Citation

Falloon, Judith, et al. "A Phase 1a, First-in-human, Randomized Study of a Respiratory Syncytial Virus F Protein Vaccine with and Without a Toll-like Receptor-4 Agonist and Stable Emulsion Adjuvant." Vaccine 34, no. 25 (2016): 2847. https://doi.org/10.1016/j.vaccine.2016.04.002.

MLA (9th ed.) Citation

Falloon, Judith, et al. "A Phase 1a, First-in-human, Randomized Study of a Respiratory Syncytial Virus F Protein Vaccine with and Without a Toll-like Receptor-4 Agonist and Stable Emulsion Adjuvant." Vaccine, vol. 34, no. 25, 2016, p. 2847, https://doi.org/10.1016/j.vaccine.2016.04.002.